New data shows persistent high antipsychotic use in long-term care homes despite targets

A recent report reveals that the use of antipsychotic drugs in long-term care homes remains alarmingly high, posing significant concerns for health care experts. Despite national targets aimed at reducing these prescriptions, the prevalent use of antipsychotic medications in Canadian care facilities has not significantly decreased. Experts, including doctors and advocates, express concern over the over-reliance on these drugs for managing behavioral issues in elderly residents. The report highlights that unnecessary antipsychotic use can lead to severe side effects, impacting the quality of life for seniors. Moreover, experts urge for better training and non-pharmacological approaches to manage dementia-related behaviors. This issue underscores the need for reforms and improved resources in long-term care settings to ensure patient safety and well-being. The stagnant progress on this front calls for urgent attention and action from policymakers and health authorities.

CBC